Clinical Trials Browser

Phase 2 × Liposarcoma × Rosiglitazone × Clear all

NCT00004180 2023-06-26

Rosiglitazone in Treating Patients With Liposarcoma

Phase 2 Completed

Liposarcoma, Sarcoma